NGNE
Neurogene Inc. · Healthcare · Market cap $521.9M
Insiders sold $173K net in the last 90 days ·1 seller, 0 buyers· 2 of 2 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 8, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Oct 2, 2026
Cvijic Christine Mikail
Neurogene Inc. (NGNE) has 14 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 4 insiders at Neurogene Inc. reported no open-market purchases and 11 open-market sales totaling $1.1M. The most active filer is President and CFO Cvijic Christine Mikail with 8 filings. Insiders have net sold $640K over the trailing 6 months. The most recent open-market filing is a sale of 600 shares by President and CFO Cvijic Christine Mikail, dated Jul 6, 2026, worth $22K.
- Industry:Biotechnology
- CEO:Rachel L. McMinn
- Employees:131
- HQ:New York City, NY, US
- IPO:2014-03-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President and CFO | Sale | 600 | $22K | Jul 8 | -31.8% | SEC ↗ | |
| President and CFO | Sale | 4,200 | $152K | Jul 8 | -31.8% | SEC ↗ | |
| President and CFO | Sale | 739 | $25K | Jul 2 | -26.2% | SEC ↗ | |
| President and CFO | Sale | 4,061 | $141K | Jul 2 | -26.2% | SEC ↗ | |
| President and CFO | Sale | 9,600 | $300K | May 8 | -15.3% | SEC ↗ | |
McMinn RachelFirst filing | Chief Executive Officer | Sale | 3,352 | $74K | Mar 30 | +35.1% | SEC ↗ |
| President and CFO | Sale | 2,558 | $55K | Mar 30 | +35.1% | SEC ↗ | |
Jordan JulieFirst filing | Chief Medical Officer | Sale | 828 | $18K | Mar 30 | +35.1% | SEC ↗ |
Cobb StuartFirst filing | Chief Scientific Officer | Sale | 6,797 | $141K | Mar 17 | — | SEC ↗ |
| President and CFO | Sale | 4,045 | $84K | Mar 17 | — | SEC ↗ | |
Cvijic Christine MikailFirst filing | President and CFO | Sale | 4,800 | $121K | Mar 3 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does NGNE have?
Neurogene Inc. (NGNE) has 14 SEC Form 4 filings (22 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for NGNE?
The most recent Form 4 filing for NGNE on Tracefour is dated Oct 2, 2026.
Who is the most active insider at NGNE?
The most active SEC Form 4 filer at NGNE in the rolling window is President and CFO Cvijic Christine Mikail, with 8 filings.
What is the net insider flow at NGNE over the last 6 months?
Over the trailing 180 days, insiders at NGNE have net sold $640K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NGNE in the current window?
Inside the rolling window, insiders at NGNE bought $0 and sold $1.1M based on SEC Form 4 filings.
Can I get alerts for NGNE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Neurogene Inc. (NGNE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Neurogene Inc. is in the Healthcare sector.